Brady W. Dougan - 29 Aug 2024 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role: Director
Signature: /s/ Brady W. Dougan by Dale A. Sander as Attorney-in-Fact
Issuer symbol: HUMA
Transactions as of: 29 Aug 2024
Net transactions value: +$7,998
Form type: 4
Filing time: 03 Sep 2024, 16:17:12 UTC
Previous filing: 29 Aug 2024
Next filing: 11 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HUMA	Common Stock	Purchase	$7,998	+1,222	+0.51%	$6.54	242,054	29 Aug 2024	By spouse	F1
holding	HUMA	Common Stock						510,161	29 Aug 2024	Direct
holding	HUMA	Common Stock						1,148,240	29 Aug 2024	By The Niklason Living Trust
holding	HUMA	Common Stock						3,677,262	29 Aug 2024	By Ayabudge LLC

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This purchase by the Reporting Person's spouse is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the sale by Ayabudge LLC, an entity controlled by the Reporting Person, of 809,786 shares of the Issuer's common stock on May 31, 2024. The Reporting Person's spouse has paid the Issuer $3,391.05, representing the full amount of profit realized in connection with this purchase.

Content

This purchase by the Reporting Person's spouse is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the sale by Ayabudge LLC, an entity controlled by the Reporting Person, of 809,786 shares of the Issuer's common stock on May 31, 2024. The Reporting Person's spouse has paid the Issuer $3,391.05, representing the full amount of profit realized in connection with this purchase.